Prescription medicines
Astellas develops and sells branded prescription drugs for use in hospitals, clinics, and pharmacies, with products in urology, oncology, immunology and transplant care, and eye care.
Customers and revenue model
Astellas Pharma Inc
XMUN:YPH
Astellas Pharma Inc
XMUN:YPH
Price:
14.74
EUR
2.47%
Market Closed
Market Cap:
€42.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Astellas Pharma Inc
XMUN:YPH
|
JP |
|
Tokyo Electron Ltd
TSE:8035
|
JP |
|
H
|
Healius Ltd
SWB:PGZ
|
AU |
|
S
|
Sega Sammy Holdings Inc
OTC:SGAMF
|
JP |
|
Z
|
Zhong An Group Ltd
F:35Z
|
CN |
|
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
|
CN |
|
B
|
Bantas Bandirma Ambalaj Sanayi ve Ticaret AS
IST:BNTAS.E
|
TR |
|
Landis+Gyr Group AG
SIX:LAND
|
CH |
|
Seagate Technology Holdings PLC
NASDAQ:STX
|
IE |
|
Carlo Gavazzi Holding AG
F:D9N0
|
CH |
|
UFP Technologies Inc
F:UFP
|
US |
|
Japan Real Estate Investment Corp
OTC:JREIF
|
JP |
|
Superland Group Holdings Ltd
HKEX:368
|
HK |
|
V
|
Vallourec SA
PAR:VK
|
FR |
|
Banque Cantonale Vaudoise
LSE:0ACP
|
CH |
|
8
|
88 Energy Ltd
LSE:88E
|
AU |
|
K
|
Kinder Morgan Inc
LSE:0JR2
|
US |
|
M
|
Meritage Homes Corp
F:MEY
|
US |
|
S
|
Swatch Group AG
XHAM:UHR
|
CH |
|
R
|
Ritchie Bros Auctioneers Inc
NYSE:RBA
|
CA |
|
G
|
Goldman Sachs BDC Inc
SWB:GSB
|
US |
|
N
|
North American Construction Group Ltd
F:N5Z
|
CA |
|
C
|
Cintas Corp
DUS:CIT
|
US |
|
Bastogi SpA
MIL:B
|
IT |
Company Overview
Business Description
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Headquarters
- Japan JP
- Employees
- 13 643
- IPO date
- May 16, 1949
Astellas Pharma is a Japanese drug company that discovers, develops, makes, and sells prescription medicines. Its main products treat areas such as urology, transplant medicine, immunology, cancer, and eye disease. The company spends heavily on research and then brings branded drugs through testing, approval, manufacturing, and distribution.
Its main customers are doctors, hospitals, pharmacies, and healthcare systems that prescribe or buy medicines for patients. Astellas makes money mostly by selling prescription drugs, along with income from licensing and partnership deals when it shares technology or rights to certain medicines with other drugmakers.
What makes Astellas different is that it sits in the high-value part of the pharmaceutical chain: it turns scientific research into approved medicines for specific diseases. That means its business depends less on high-volume commodity sales and more on a smaller number of branded treatments that are protected by patents and supported by medical data.
Continue YPH Research
Other Astellas Pharma Inc listings:
